Abstract
The use of hypothalamic releasing hormones for the clinical assessment of anterior pituitary function is both simple and free of severe side effects. Tests with the recently discovered substances GRF and CRF as well as with combinations of several releasing hormones are therefore used in many clinics. A reliable interpretation of such combined tests, however, is only possible when positive or negative interactions between these releasing hormones are known. After a rest of 2 h to reach basal Cortisol levels, 7 groups of 5 male volunteers each received an iv bolus injection consisting of either: A): GRF (100 µg) + CRF (50 µg) + TRH (200 jug) + LHRH (100 µg), B): CRF + TRH, C): GRF + TRH, D): LHRH + TRH, E): TRH, F): GRF, G): CRF. During the following 2 h, GH, TSH, Cortisol, LH, FSH and prolactin were measured every 15 min. The TSH response after the injection of all 4 releasing hormones was significantly higher (Δ TSH = 16.5 ± 2.0 µU/ml, x ± SE) compared to the injection of TRH alone (Δ TSH = 9.3 ± 1.4 µU/ml; p< 0.025). This increment in TSH secretion was confirmed when 2 groups of 5 female volunteers were studied with the TRH-test (Δ TSH = 9.9 ± 1.8 µU/ml) or the combination of all four releasing hormones (Δ TSH = 16.8 ± 2.9 µU/ml; p < 0.05). Thisexaggerated TSH-response to TRH was demonstrated to be entirely due to simultaneous administration of GRF, whereas CRF and LHRH in combination with TRH had no additional effecton TSH release. For all other hormones measured no significant differences could be found between single and combined tests.
Similar content being viewed by others
References
Gelato M.C., Merriam G.R., Vance M.L., Goldman J.A., Webb C., Evans W.S., Rock J., Oldfield E.H., Moltich M., Rivier J., Vale W., Reichlin S., Frohman L.A., Loriaux D., Thorner M.O. Effects of growth-hormone releasing factor on growthhormone secretion in acromegaly. J. Clin. Endocrinol. Metab. 60: 251, 1985.
Laron Z., Keret R., Bauman B., Pertzelan A., Ben-Zeev Z., Olsen D.B., Comaru-Schally A.M., Schally A.V. Differential diagnosis between hypothalamic and pituitary hCG deficiency with the aid of synthetic GH-RH 1-44. Clin. Endocrinol. (Oxf.) 21: 9, 1984.
Schriock E.A., Lustig R.H., Rosenthal S.M., Kaplan S.L., Grumbach M.M. Effect of growth hormone releasing hormone on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: Evidence for hypothalamic GHRH deficiency. J. Clin. Endocrinol. Metab. 58: 1043, 1984.
Takano K., Hizuka N., Shizume K., Asakawa K., Miyakawa M., Hirose N., Shibasaki T., Ling N.C. Plasma growth hormone response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism. J. Clin. Endocrinol. Metab. 58: 236, 1984.
Mueller O.A., Doerr H.G., Hagen B., Stalla G.K., v. Werder K. Corticotropin releasing factor. Stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis. Klin. Wochenschr. 60: 1485, 1982.
Orth D., DeBold C.R., DeCherney G.S., Jackson R.V., Alexander A.N., Rivier J., Rivier C., Spiess J., Vale W. Pituitary microadenomas causing Cushing’s disease respond to corticotropin-releasing factor. J. Clin. Endocrinol. Metab. 55: 1017, 1982.
Orth D., Jackson R.V., DeCherney G.S., DeBold C.R., Alexander A.N., Island D.P., Rivier J., Rivier C., Spiess J., Vale W. Effect of synthetic ovine corticotropin-releasing factor. J. Clin. Invest. 71: 587, 1983.
Holl R., Fehm H.L., Hetzel W.D., Heinze E., Voigt K.H. Globaler Hypophysen-Stimulationstest mit Releasing-Hormonen. Dtsch. Med. Wochenschr. 110: 953, 1985.
Sheldon W.R., DeBold C.R., Evans W.S., DeCherney G.S., Jackson R.V., Island D.P., Thorner M.O., Orth D.N. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects. J. Clin. Endocrinol. Metab. 60: 623, 1985.
Murphy B.E.P Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurements of various steroids in body fluids by competitive protein-binding radioassay. J. Clin. Endocrinol. Metab. 27: 973, 1976.
Cohen R., Bouquier D., Biot-Laporte S., Vermeulen E., Claustrat B., Cherpin M.-H., Cabrera P., Guidetti P., Ferry S., Bizollon Ch.A., Sassolas G. Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients. J. Clin. Endocrinol. Metab. 62: 892, 1986.
Evain-Brion D., Gamier P., Schimpf R.M., Chaussain J.L., Job J.C. Growth hormone response to thyrotropin-releasing hormone and oral glucose loading tests in tall children and adolescents. J. Clin. Endocrinol. Metab. 56: 429, 1983.
Irie M., Tsushima T. Increases of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. J. Clin. Endocrinol. Metab. 35: 97, 1972.
Maeda K., Kato Y., Yamaguchi N. Growth hormone release following thyrotropin releasing hormone injection into patients with anorexia nervosa. Acta Endocrinol. (Kbh.) 81: 1, 1976.
Gonzales-Barcena D., Kastin A.J., Schalch D.S. Responses to thyrotropin releasing hormone in patients with renal failure and after infusion in normal men. J. Clin. Endocrinol. Metab. 36: 117, 1973.
Borges J.L.C., Uskavitch D.R., Kaiser D.L., Cronin M.J., Evans W.S., Thorner M.O. Human pancreatic growth hormone-releasing factor-40 (hpGRF-40) allows stimulation of GH release by TRH. Endocrinology 113: 1519, 1983.
Thorner M.O., Perryman R.L., Cronin M.J., Rogol A.D., Draznin M., Jobanson A., Vale W., Horvath E., Kovacs K. Somatotroph Hyperplasia: Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J. Clin. Invest. 70: 965, 1982.
Davis J.R.E, Sheppard M.C. Modulation of thyrotropin release from an intracellular pool by pre-exposure to thyrotropin-releasing hormone and dibutyryl-cyclic-AMP. J. Endocrinol. 108: 211, 1986.
Weeke J., Hanson A.P., Lundbaek K. The inhibition by somatostatin of the thyrotropin response to thyrotropin-releasing hormone in normal subjects. Scand. J. Clin. Lab. Invest. 323: 101, 1974.
Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.
Wehrenberg W.B., Baird A., Ying S., Rivier C., Ling N., Guillemin R. Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors. Endocrinology 114: 1995, 1984.
Root A.W., Bongiovanni A.M., Eberlein W.R.. Inhibition of thyroidal radioiodine uptake by human growth hormone. J. Pediatr. 76: 422, 1970.
Tannenbaum G.S. Evidence for autoregulation of growth hormone secretion via the central nervous system. Endocrinology 107: 2117, 1980.
Vigh S., Schally A.V. Interaction between hypothalamic peptides in a super-fused pituitary cell system. Peptides 5: 241, 1984.
Ingram C.D., Bicknell R.J. Synergistic interaction in bovine pituitary cultures between growth hormone-releasing factor and other hypophysiotropic factors. J. Endocrinol. 109: 67, 1986.
Sandler L.M., Burrin J.M., Joplin G.F., Bloom S.R. Combined use of vasopressin and synthetic hypothalamic releasing factors as a new test of anterior pituitary function. Br. Med: J. 292: 511, 1986.
Author information
Authors and Affiliations
Additional information
This paper was presented in part at the second Joint Meeting of the Pediatric Research Societies in Europe, Munich, 1985.
Rights and permissions
About this article
Cite this article
Holl, R.W., Loos, U., Hetzel, W.D. et al. Combined pituitary stimulation test: interactions of hypothalamic releasing hormones in man. J Endocrinol Invest 11, 219–223 (1988). https://doi.org/10.1007/BF03350139
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350139